Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Jupiter Pharmaceuticals Ltd, is an unlisted public company incorporated on 28 October, 1976. It is classified as a public limited company and is located in Parganas North, West Bengal. It's authorized share capital is INR 1.25 cr and the total paid-up capital is INR 1.01 cr.
Jupiter Pharmaceuticals Ltd's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 26.33% over the previous year. At the same time, it's book networth has increased by 36.54%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2022 numbers.
15.87%
26.33%
40.53%
36.54%
32.32%
39.48%
1.01
1.59
1.94
0.72
15.52
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(11)
| State | Type | Address |
|---|---|---|
| West Bengal | Registered Office | SYNTHESIS BUSINESS PARK, 9C(A), 9TH FLOOR ACTION AREA -II, NEWTOWN KOLKATA Parganas North West Bengal - 700157 |
| Bihar | Warehouse, Sales Office | 0, H/O DIWAKAR PRASAD, ANANT BAGH PAHALWAN GATE, KANKARBAGH, Patna, Patna, Bihar, 800020 |
| Bihar | Warehouse, Sales Office | GROUND FLOOR, 0, H/O RAJDEO PRASAD, SWARAJ PATH, TILAK NAGAR KANKARBAGH, Patna, Bihar, 800020 |
| Assam | Warehouse, Sales Office | 0, Shree Shyam Tower, NH-37, Lokhra Chariali Beltola, Kamrup Metropolitan, Assam, 781034 |
| West Bengal | Factory | 9TH FLOOR, 9C A, SYNTHESIS BUSINESS PARK, ACTION AREA- II, NEWTOWN, North Twenty Four Parganas, West Bengal, 700156 |
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Bank Limited
No. of Loans: 1
Total Amount : 5.0 cr
GE Capital Transportation Financial Services Limited
No. of Loans: 1
Total Amount : 0.1 cr
Total Amount : 5.0 cr
Charge Date : 13 Jan, 2023
Total Amount : 0.1 cr
Charge Date : 27 Jun, 2007
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Gour Pada Sarkar
Shareholder
|
00401243 | 49 years |
| Managing Director | Mriganka Kishore Sarkar
Shareholder
|
00401438 | 18 years |
| Director | Shyamasree Sarkar
Shareholder
|
06946748 | 11 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| DR. SARKAR ALLEN AYUSH RESEARCH INSTITUTE PRIVATE LIMITED |
Active
|
50.0 L | 2 | West Bengal |
| EMARS PERK ALLEN PRIVATE LIMITED |
Active
|
10.0 L | 1 | West Bengal |
| FEDERATION OF HOMEOPATHIC MANUFACTURERS OF INDIA |
Active
|
0.0 | 1 | Delhi |
| ALLEN BIOPHARMA LIMITED |
Active
|
1.1 Cr | 1 | West Bengal |
| ALLEN'S HOUSING & FINANCE LIMITED |
Active
|
2.0 Cr | 2 | West Bengal |
| ALLEN'S INDIA LTD. |
Active
|
1.0 Cr | 1 | West Bengal |
| ALLEN AYUR INDIA PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | West Bengal |
| ALLEN AQUA FOOD & DRUG PRIVATE LIMITED |
Active
|
2.0 Cr | 2 | West Bengal |
| QUALITY ALLEN PHARMA PRIVATE LIMITED |
Active
|
13.2 L | 2 | West Bengal |
| ALLEN INDUSTRIES LIMITED |
Active
|
96.7 L | 3 | West Bengal |
| ALLEN AD & PUBLICITY PRIVATE LIMITED |
Active
|
1.5 Cr | 1 | West Bengal |
| ALLEN LABORATORIES LTD |
Active
|
8.8 Cr | 2 | West Bengal |
| ALLEN HEALTHCARE CO LIMITED |
Active
|
2.0 Cr | 1 | West Bengal |
| FINOP DRUGS PVT.LTD. |
Active
|
25.0 L | 2 | West Bengal |
The incorporation date of JUPITER PHARMACEUTICALS LTD is 28 October, 1976
The authorized share capital of JUPITER PHARMACEUTICALS LTD is INR ₹ 1.2 Cr.
The paid-up capital of JUPITER PHARMACEUTICALS LTD is INR ₹ 1.0 Cr.
The registered address of JUPITER PHARMACEUTICALS LTD is SYNTHESIS BUSINESS PARK, 9C(A), 9TH FLOOR ACTION AREA -II, NEWTOWN KOLKATA Parganas North West Bengal - 700157
The CIN number of JUPITER PHARMACEUTICALS LTD is U24239WB1976PLC030746.
Expand
Delete
Collapse
See
details
